Gout Associated With Psoriatic Arthritis, Psoriasis in Adults

What does rheumatoid arthritis feel like?
November 27, 2018
Finally, My MS Journey Includes Good News to Report
November 27, 2018
Show all

Gout Associated With Psoriatic Arthritis, Psoriasis in Adults

Data show an increased prevalence of psoriasis in patients with gout compared with patients without gout.

Patients with gout may experience a higher prevalence of inflammatory skin conditions including psoriasis and psoriatic arthritis (PsA), according to study results published in the Journal of the European Academy of Dermatology and Venereology.

Researchers analyzed cross-sectional data from the Taiwanese National Health Insurance Research Database. The study cohort consisted of 114,623 patients with gout propensity score-matched (1:1) based on common characteristics such as age, income, sex, and urbanization level. The same number of patients without gout was included as controls. Using logistic regression, researchers estimated the prevalence of PsA, psoriasis, and other comorbid diseases in both patient groups.

After statistical analysis, the investigators found that in the gout group there was a significantly increased prevalence of psoriasis when compared with the control group (1.6% vs 1.1%, respectively; P <.0001). In addition, subgroup analysis comparing both groups showed an increased percentage of patients with gout with comorbid PsA (0.3% vs 0.1%, respectively; P<.0001).

Logistic regression data further revealed significant associations between gout, PsA (adjusted odds ratio [OR], 1.30; 95% CI, 1.20-1.42; P <.0001), and psoriasis (adjusted OR, 2.50; 95% CI, 1.95-3.22; P <.0001). The strongest association was in patients aged 41 to 50 years.

Read on: Gout Associated With Psoriatic Arthritis, Psoriasis in Adults

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.